throbber
Dr. Reddy’s Laboratories, Inc. v. Celgene Corp.
`IPR2018-01509
`Exhibit 2033, Page 1
`
`

`

`Dr. Reddy’s Laboratories, Inc. v. Celgene Corp.
`0
`
`Exhibit 2033, Page 2
`
`

`

`
`
`kI)a. are expressed on B and T cells. endothelial. epithelial.
`and dendritic cells. fibroblasts. kcratinocytes. and chondro—
`cytes. They are inducible in I244 hours by cytokines such as
`gamma interferon. interleukin-1B. and tumour necrosis factor-
`0. Example (human. precursors):
`lCAM~l major group rhi-
`novirus receptor: database code lCALHUMAN. 532 amino
`acids (57.76 kDa). [CAM-2 lur CD101). of molecular mass
`556.5 kDa. are constitutively expressed on endothelial cells.
`some lymphocytes. monocytes, and dendritic cells. Example
`(human): database code |CA2_HLIMAN. 275 amino acids
`(30.6: kDa). lCAM-3 (or C050). of molecular mass “6.7140
`kDa. are constitutively expressed on monocytes. granulocytes.
`and lymphocytes; upon physiological stimulation they become
`rapidly and transiently phosphorylated on scrine residues. Ex-
`ample (human): database code [CALHLTMAN 547 amino
`acids (59.32 kDa).
`ICD (in clinical t'hcriii’xiryl uhhr. for isocitrate dehydrogenase
`(EC l.I.t.4ti,
`ice the solid form of water that can exist at temperatures below
`the triple point of water (273.16 K at lUl 325 Pa).
`iceberg a metaphor used to describe an interpretation of the
`anomalous entropies of solution of noble gases and other non-
`polar substances in water. suggesting that water tends to organ-
`ize itself into quasi-solid supramolecular structures around the
`molecules of such substances. in the case ofalkyl compounds.
`this tendency increases markedly with the length of the alkyl
`chain.
`ICE-like protease any of a family of endopeptidases that
`structurally resemble interleukin-13 commmse (ICE). They are
`involved in apoptosit. being implicated in the proteolysis that
`causes cell death.
`Icoll
`l or CCK cell any of a group of cells. widely distributed
`in the duodenal and jejunal mucosa. that produce cholecysto-
`ltinin. So named because their histological features are inter-
`mediate between those of 8 calls and L cells. 2 uhhr.
`jar
`inclusion cell. See also lvcell disease.
`I-coll disease or inclusion-cell disease or mucolipidosis ll an
`autosomal recessive disease in which most of the lysosomes in
`the connective tissue (fibroblasts) contain large inclusions of
`glycoaminoglycans and glycolipids as a result of the absence
`of several
`lysosomal hydrolases. These enzymes. which are
`synthesized in the endoplasmic reticulum. are secreted into the
`extracellular medium rather than being directed to the lyso<
`somes. This is due to the absence of a mannose 6-phosphatc
`marker on the carbohydrate moieties of these hydrolases be-
`cause of a deficiency in an enzyme required for mannose phos—
`phorylation. The failure of the phosphorylation in the ('M'
`Golgi network means that the enzymes are not segregated by
`the iniinnosc 5-pliosphate receptors into the appropriate transport
`vesicles in the trans Golgi network. The patients have an ab-
`normally high level of lysosomal enzymes in their sera and
`body fluids. A milder form of l-cell disease is Hurler's pol)-
`dystrophy (Nude! syndrome).
`ice point the temperature at which ice melts. It is taken as the
`temperature (27],IS K) at which ice and water are in equilib-
`rium at standard pressure (101 325 Pa). It was used as a refer-
`ence temperature on the (‘elsms scale. but the kelvin is based
`instead on the temperature at the triple point of water (273.16 K ).
`ICF uhbr, for intracellular lluid.
`lchthyotocin an alternative name for isotocin.
`icosa+ or I'ht-jbri» a mutt/I icos+ romh. form recommended for
`denoting twenty or twenty times. Also (formerly): eicosao.
`eicos+. (Note: the eicosla)+ variant is still always used for the
`(Tm fatty acids and skeletally related compounds. e.g the
`eicosanoids.)
`icoudeltahodron (pl. icosldeltabedra) any solid geometrical
`
` tl lX iltii
`
`iri'mboljm l iso (def. 3); (as a prefix or superscript in symbols
`and abbreviations for iso compounds or groups; c.g. isopropyl
`can be symbolized as iPr or Pr‘). 2 the chemical group 2-
`isopentenyl; 3.3-dimethylallyl
`(as a prefix to a single-letter
`symbol for a nucleoside residue to deSignate substitution of
`the base. as in M). 3 the square root of~~-l.
`isi'mhuljbr 1 electric current (alternative to I). 2 van‘t Hoff fac-
`tor.
`
`lxymbol for I iodine. 2 an iodo group in an organic compound
`3 a residue of the a-amino acid i-isoleucine (alternative to
`He). 4 a residue of the ribonucleoside inosine (alternative to
`lno).
`I .rymholfor I electric current (preferred alternative to i). Z in-
`tenstty; the subscripts e (for energetic). p (for photon). or v
`(for visible) may be added to distinguish between radiant in-
`tenstty. photon intensity. and luminous intensity. respectively,
`3 ionic strength: the subscripts c or m may be added to indi-
`cate whether it is expressed based on concentration or molal-
`ity respectively. 4 the inductive effect of a particular chemical
`group in an organic compound.
`IA .V)’I71btll_f-(Ir N°-(2-isopentenyl)adenosme. a hyponnodiliod base.
`IAA ahbr. for indole-3—acetic acid or indoleacctate.
`IAN ahbr. for indoleacetonitrile.
`IAP abbr. for islet-activating protein; .i't’t‘ pomissis toxin.
`iatrogenic describing a condition or disease induced uninten-
`tionally by a physician through his or her diagnosis. manner.
`or therapy. fiintrogenicity n,
`l-band abhr. for isotropic band. The l-bands of striated muscle
`contain the thin filaments and correspond to the light bands.
`The name derives from the fact that they are isotropic in po-
`larized light. Soc also urcomore.
`IBMX ahhr. for isobutylmethylxanthine.
`Ibuprofen 2-(4’isobutylphenyl)propionic acid; a nonsteroidal
`anti-inflammatory agent of the substituted propionic acid
`type; others of this type are flurbiprofen. kaloprolen. and
`naproxen. They inhibit the cyclooxygenase activity of prosta-
`glandin-ondopemxide synthese. reversibly over short time inter-
`vals. followed by time—dependent irreversible inactivation. due
`probably to conformational rather than covalent changes. The
`racemic mixture is present
`in many over-the—countcr drugs.
`but the ('Sl-enantionier is the active form. Prtlprlt’lul‘ll' mum's
`include: Advil: Brufen; Motrin,
`
`
`
`(Si-ibuproten
`
`it: or i.c. (1th (or iiitracutaiieous or intracutancously
`IC ahhr. for internal conversion
`l) of an
`IO“ 1 the median inhibitory concentration (in mol l.
`antagonist. re the concentration that reduces a spec‘ified re-
`sponse to 5(% of its former value; nnnpure EC”. 2 the median
`inhibitory concentration (in mol L“) of an agent (agonist or
`antagonist). i.e. the concentration that causes a 50“.» reduction
`in the specific binding of a radioligand.
`ICAM abbr. for intercellular adhesion molecule: any of several
`type I membrane glycoproteins of the immunoglobulin super-
`family. They act as ligands for leukocyte adhesion to target
`cells.
`in conjunction with “AA: in fact LFA-l—lCAM links
`mediate adhesron between many cell
`types. There are three
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket